Skip to main content
Screener/Healthcare/Biotechnology

LXRX Lexicon Pharmaceuticals, Inc.

NASDAQ
$1.93+0.25 (+14.88%)
$0.51
$2.00
$1.64
$1.93
EPS (TTM)$-0.14
P/E Ratio-11.98
Dividend Yield
Market Cap$677.9M
Volume5.65M
Prev Close$1.68
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$5.5M-$15.5M$-0.0494.2%-282.7%
Q3 '25$14.2M-$12.8M$-0.0499.9%-90.0%
Q2 '25$28.9M$3.3M$0.0199.3%11.3%
Q1 '25$1.3M-$25.3M$-0.0797.6%-2004.4%
Q4 '24$26.6M-$33.8M$-0.092.3%-127.2%
Q3 '24$1.8M-$64.8M$-0.1895.9%-3703.5%
Q2 '24$1.6M-$53.4M$-0.1789.9%-3244.0%
Q1 '24$1.1M-$48.4M$-0.2084.5%-4282.9%
Get Your Daily Market Recap